These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 20407768)

  • 41. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
    Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
    Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
    Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
    Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
    Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
    Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
    Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
    World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
    Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
    Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center.
    Garancini M; Nespoli S; Romano F; Uggeri F; Degrate L; Okolicsanyi S; Gianotti L
    J Visc Surg; 2018 Sep; 155(4):275-282. PubMed ID: 29606603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma.
    Suh SW; Choi YS
    Yonsei Med J; 2017 Jul; 58(4):737-742. PubMed ID: 28540985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Biolato M; Gallusi G; Iavarone M; Cabibbo G; Racco S; De Santis A; Corte CD; Maida M; Attili AF; Sangiovanni A; Cammà C; La Torre G; Gasbarrini A; Grieco A
    Ann Hepatol; 2018; 17(1):110-118. PubMed ID: 29311396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.
    Li J; Huang L; Liu CF; Cao J; Yan JJ; Xu F; Wu MC; Yan YQ
    World J Gastroenterol; 2014 Jul; 20(27):9121-7. PubMed ID: 25083085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm.
    Pandrowala S; Patkar S; Goel M; Mirza D; Mathur SK
    Langenbecks Arch Surg; 2023 Apr; 408(1):144. PubMed ID: 37041364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
    Chen J; Lai L; Lin Q; Huang W; Cai M; Zhu K; Huang M
    Oncotarget; 2017 Jan; 8(1):408-417. PubMed ID: 27880724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].
    Guo Z; Xiang B; Zhang J; Jiang J; Li L
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1526-9. PubMed ID: 25146737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sorafenib with TACE improves the survival of hepatocellular carcinoma patients with more than 10 cm tumor: a single-center retrospective study.
    Aktas G; Kus T; Emin Kalender M; Kervancioglu S; Sevinc A; Kul S; Camci C
    J BUON; 2017; 22(1):150-156. PubMed ID: 28365948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.
    Torzilli G; Donadon M; Marconi M; Palmisano A; Del Fabbro D; Spinelli A; Botea F; Montorsi M
    Arch Surg; 2008 Nov; 143(11):1082-90. PubMed ID: 19015467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.
    Liu W; Zhou JG; Sun Y; Zhang L; Xing BC
    J Gastrointest Surg; 2015 Jul; 19(7):1271-80. PubMed ID: 25943910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of hepatocellular carcinoma: beyond international guidelines.
    Colombo M; Sangiovanni A
    Liver Int; 2015 Jan; 35 Suppl 1():129-38. PubMed ID: 25529098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conventional Ethiodized Oil Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma: Contemporary Single-Center Review of Clinical Outcomes.
    Casadaban LC; Minocha J; Bui JT; Knuttinen MG; Ray CE; Gaba RC
    AJR Am J Roentgenol; 2016 Mar; 206(3):645-54. PubMed ID: 26901023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.